Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer.
Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer. Cancer Res. 1987 Apr 01; 47(7):1952-6.